BMYMP News and Press, Bristol-Myers Squibb $2Pr From 07/27/23

2023-07-27 12:37:08 ET Bristol-Myers Squibb Company (BMY) Q2 2023 Earnings Call Transcript July 27, 2023 08:00 AM ET Company Participants Timothy Power - VP & Head, IR Giovanni Caforio - Chairman & CEO David Elkins - EVP & CFO Christopher Boerner ...

2023-07-26 22:03:49 ET Summary My U.S. dividend growth portfolio, constructed in 2015, has outperformed the market by over 2% annually. The portfolio was designed to be resilient in a major stock market correction, focusing on dividend achievers with at least 10 years of dividend ...

2023-07-24 18:21:28 ET Summary Bristol-Myers Squibb Company made a $35 million equity investment into Immatics N.V. The partnership with Bristol-Myers Squibb brought $15 million opt-in payment; Immatics also is eligible to earn up to $490 million in milestone payments in addition ...

2023-07-23 05:45:00 ET Summary Novartis has signed a $1 billion deal to acquire DTx Pharma - DTx Pharma shareholders will receive $500 million upfront and up to $500 million in milestones. Sichuan Kelun-Biotech completed a $174 million IPO on the Hong Kong Exchange, valuing the co...

2023-07-23 01:07:37 ET Summary Bristol-Myers Squibb is expected to report its Q2 results on July 27, with market sentiments highly pessimistic, heading into its earnings release. The company faces revenue challenges due to the loss of exclusivity for Revlimid. I gleaned that the m...

2023-07-21 11:08:50 ET Summary On July 27, 2023, Bristol-Myers Squibb, one of the leaders in the global cancer and immunology therapeutics market, will release its financial report for the second quarter of 2023. In the first half of 2023, the company delighted investors with nume...

2023-07-21 10:34:33 ET Summary The article presents the top 19 highest-quality Dividend Contenders, companies that have consistently higher annual dividend payouts for 10–24 years. I use a quality scoring system to rank candidates, and Microsoft, Visa, and Costco Wholesale ...

2023-07-14 09:15:00 ET Summary Distillate Capital Partners LLC was formed in 2017 and is based in Chicago, IL. The firm is 100% employee-owned, and DCP’s partners each have invested significantly in the firm’s investment strategies. A strong rally moved market levels...

2023-07-14 02:42:54 ET Summary In 2015, I started publishing updates regarding my dividend growth portfolio, and I keep doing so every quarter. This is part of being transparent with my readers, so they can see what I hold and its correlation with my writing. This article summ...

2023-06-30 14:38:56 ET Summary Evotec SE caught a 34% bid over the last 6 months. Despite growth in customers and R&D partnerships, further clarifications are needed for the investor to avoid buying on speculation. Whilst emerging trends in the firm's operations are constr...